BLAKE YOUNG: Open Payments
NPI 1427727957 · LOUISVILLE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 38 payments from 15 companies in 2025. Trend: 2023 $1,611 · 2024 $1,810 · 2025 $843
Food & beverage: $843
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 6 | $191 |
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| Axsome Therapeutics, Inc. | 6 | $87 |
| HARMONY BIOSCIENCES LLC | 3 | $78 |
| GENZYME CORPORATION | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Lilly USA, LLC | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Verona Pharma, Inc. | 2 | $37 |
| Insmed, Inc. | 1 | $31 |
Products named: XYWAV, DUPIXENT, Sunosi, WAKIX, FASENRA, TEZSPIRE, Ohtuvayre, NUCALA.
Industry payments across CO — which companies pay providers there.
